Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rx: higher prices.

J Kosterlitz

    National Journal
    |January 20, 1993
    PubMed
    Summary
    This summary is machine-generated.

    US prescription drug costs are high. To address this, trade deals are being pursued that may increase medication prices globally.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Income security. Do it yourself.

    National journal·1996
    Same author

    Stern measures.

    National journal·1996
    Same author

    Rise of the medical savings account.

    National journal·1996
    Same author

    Unmanaged care?

    National journal·1994
    Same author

    Doctors' lobby tries to heal itself.

    National journal·1994
    Same author

    Signs of life in the wreckage.

    National journal·1994

    Area of Science:

    • Health Economics
    • International Trade Policy
    • Pharmaceutical Market Analysis

    Background:

    • The United States faces exceptionally high prescription drug prices compared to other nations.
    • There is a recognized need to address the escalating costs of pharmaceuticals.

    Purpose of the Study:

    • To examine the implications of U.S. trade policies on global prescription drug pricing.
    • To analyze the strategies employed by U.S. trade officials and the pharmaceutical industry regarding international drug prices.

    Main Methods:

    • Analysis of current international trade agreements and negotiations.
    • Review of pharmaceutical industry lobbying efforts and policy recommendations.
    • Comparative study of drug pricing mechanisms across different countries.

    Related Experiment Videos

    Main Results:

    • U.S. trade officials and the pharmaceutical industry are actively advocating for trade agreements.
    • These agreements are designed with provisions that could lead to increased prescription drug prices in other countries.
    • The strategy aims to harmonize pricing standards, potentially impacting global affordability.

    Conclusions:

    • The pursuit of specific trade agreements represents a proactive measure by the U.S. to influence global drug pricing.
    • This approach may exacerbate affordability issues in other nations while potentially addressing domestic price concerns.
    • Further research is needed to fully understand the long-term economic and health consequences of these trade policies.